CoChat

ImmunoDip®: An Improved Screening Method for Microalbuminuria

Davidson, Mayer B., Bazargan, Mohsen, Bakris, George, Peters Harmel, Anne, Campese, Vito, Basta, Emad · 2004 · American Journal of Nephrology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Background: It is important to test for microalbuminuria in patients with diabetes, hypertension and possible insulin resistance syndrome. Current screening methods are suboptimal. This study evaluates a new office screening test for microalbuminuria that utilizes a monoclonal antibody against human serum albumin (ImmunoDip®). Methods: 182 urine samples were collected from patients attending diabetes, nephrology or hypertension clinics. The ImmunoDip® screening test was carried out in the 182 samples after which albumin and creatinine concentrations were measured quantitatively in a reference laboratory. Results: Screening the 182 patient samples with ImmunoDip® and designating an albumin:creatinine ratio of ≧30 µg/mg as positive yielded a sensitivity of 96%, a specificity of 80%, a positive predictive value (PPV) of 66% and a negative predictive value (NPV) of 98%. The reduced specificity and PPV were not due to an intrinsic inaccuracy with ImmunoDip® screening of these samples, but rather was shown to be due to the discordance between the accepted upper limits of normal for the albumin:creatinine ratio (30 µg/mg) and the albumin concentration (20 mg/l), the latter corresponding to a ratio of 20 µg/mg. In 35 samples with albumin concentrations of 20–50 mg/l, ImmunoDip® screening yielded only one false negative (FN) result. Conclusions: ImmunoDip® is an excellent screening tool for microalbuminuria.

Overview

Integrity signals

Registry

Crossref · 10.1159/000077854

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 3

  1. 10.1001/jama.271.4.275 · doi:10.1001/jama.271.4.275 · Paper page
  2. 10.1002/(SICI)1096-9136(199602)13:2<120::AID-DIA6>3.3.CO;2-6 · doi:10.1002/(sici)1096-9136(199602)13:2<120::aid-dia6>3.3.co;2-6
  3. 10.1001/archinte.156.3.286 · doi:10.1001/archinte.156.3.286 · Paper page

Cited by

See all 9

Metadata

Authors
Davidson, M. B., Bazargan, M., Bakris, G., Peters Harmel, A., Campese, V., & Basta, E.
Affiliations
  • Charles R. Drew University of Medicine and Science (US)
  • Rush University Medical Center (US)
  • University of Southern California (US)
Venue
American Journal of Nephrology
Publisher
S. Karger AG
Published
2004
Volume
24
Issue
3
Pages
284-288
ISSN
  • 0250-8095 (ISSN-L)
  • 1421-9670
OpenAlex
W2000309040
Cited by
9
References
31
Citations by year
2024: 1 · 2023: 2 · 2014: 1 · 2012: 1
FWCI
0.22
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • American Journal of Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u01dk054047-06)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK54047)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
microalbuminuria, monoclonal antibody assay, albumin-creatinine ratio, sensitivity and specificity, diabetic nephropathy, hypertension, metabolic syndrome, false-negative results
MeSH terms
Albuminuria, Humans, Reagent Strips

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ImmunoDip®: An Improved Screening Method for Microalbuminuria. https://app.cochat.ai/papers/10.1159/000077854
The paper
Davidson, M. B., Bazargan, M., Bakris, G., Peters Harmel, A., Campese, V., & Basta, E. (2004). ImmunoDip®: An Improved Screening Method for Microalbuminuria. American Journal of Nephrology. https://doi.org/10.1159/000077854

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.